Working Bibliography

Rapaport, Lisa. “Another look at the surge in EpiPen costs.” Reuters, Thomson Reuters, 27 Mar. 2017, www.reuters.com/article/us-health-epipen-costs/another-look-at-the-surge-in-epipen-costs-idUSKBN16Y24O. Accessed 8 Sept. 2017.

Mangan, Dan. “Mylan hit with racketeering suit over big price hikes of          EpiPen.” CNBC, CNBC, 3 Apr. 2017, www.cnbc.com/2017/04/03/mylan-hit-    with-racketeering-suit-over-big-price-hikes-of-epipen.html. Accessed 8 Sept.  2017.

Pollack, Andrew. “Drug Goes From $13.50 a Tablet to $750, Overnight.” The New York Times, The New York Times, 20 Sept. 2015, www.nytimes.com/2015/09/21/business/a-huge-overnight-increase-in-a-drugs-price-raises-protests.html?mcubz=1. Accessed 8 Sept. 2017.

 

Yu, Nancy, et al. “R&D Costs For Pharmaceutical Companies Do Not Explain Elevated US Drug Prices.” Health Affairs, healthaffairs.org/blog/2017/03/07/rd-costs-for-pharmaceutical-companies-do-not-explain-elevated-us-drug-prices/. Accessed 8 Sept. 2017.